The elevated m6A level and impaired expression of osteogenic markers further support the crucial role of ALKBH5 in regulating the osteogenic differentiation process in peri-implantitis combined with type II diabetes. This evidence concerns the gene ALKBH5 and type 2 diabetes mellitus.